Status:
COMPLETED
Buddy Relationships in DermatoloGic Excisions for Skin Cancer
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Skin Cancer Face
Quality of Life
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
More than 5 million skin cancer surgeries are performed each year in the United States with 80% of tumors appearing on the head and neck. Facial skin cancer diagnosis negatively affects patient qualit...
Detailed Description
Skin cancer is a common, often chronic condition that negatively impacts patient quality of life. Currently, more than 5 million skin cancer surgeries are performed in the United States each year, at ...
Eligibility Criteria
Inclusion
- Eligible candidates will be English-speaking adults with non-metastatic facial skin cancers.
Exclusion
- Candidates with severe symptoms of mood, anxiety, or substance use at time of recruitment screening. Participants who require interdisciplinary collaboration (e.g. MMS + plastic surgery, ENT, etc.) for treatment of their facial skin cancer.
Key Trial Info
Start Date :
October 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 27 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04036344
Start Date
October 12 2018
End Date
August 27 2019
Last Update
March 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States, 19104